Is alkaline phosphatase a transaminase, and how does it compare to ALT and AST in evaluating liver injury?

Alkaline Phosphatase is NOT a Transaminase

Alkaline phosphatase (ALP) is fundamentally different from transaminases (ALT and AST) in both biochemical function and clinical interpretation—ALP indicates cholestatic liver injury or bile flow obstruction, while transaminases reflect hepatocellular damage. 1

Key Biochemical Distinctions

Transaminases (ALT and AST)

• Hepatocellular enzymes that leak from damaged liver cells into serum during hepatocyte injury and necrosis 1
• ALT is highly liver-specific due to low concentrations in other tissues (skeletal muscle, kidney) 1
• AST is less specific and can be elevated from heart, skeletal muscle, kidneys, brain, and red blood cells 1
• Normal ALT: 29-33 IU/L (men), 19-25 IU/L (women) 1, 2

Alkaline Phosphatase (ALP)

• Cholestatic enzyme that rises with biliary obstruction or impaired bile flow 1
• Elevated in cholestatic liver disease with or without bilirubin elevation 1
• When ALP is elevated in isolation, suspect cholestatic disease origin 1

Clinical Pattern Recognition

Hepatocellular Pattern

• Disproportionate elevation of ALT/AST compared to ALP 3, 2
• Indicates direct hepatocyte damage from:
  • Viral hepatitis (A, B, C)
  • Fatty liver disease (NAFLD/alcoholic)
  • Drug-induced liver injury
  • Autoimmune hepatitis
  • Wilson disease
  • Hemochromatosis 1

Cholestatic Pattern

• Disproportionate elevation of ALP compared to ALT/AST 3, 1, 2
• Indicates bile flow obstruction or cholestasis from:
  • Biliary obstruction
  • Primary biliary cholangitis
  • Primary sclerosing cholangitis 2

Severity Classification for Transaminases

The degree of aminotransferase elevation guides urgency 1:

• Mild: <5× upper reference limit
• Moderate: 5-10× upper reference limit
• Severe: >10× upper reference limit

Critical Pitfall to Avoid

Do not confuse these enzyme patterns. When evaluating abnormal liver tests, first determine whether the pattern is hepatocellular (high transaminases) or cholestatic (high ALP), as this fundamentally changes your diagnostic approach and imaging strategy 3, 1. The 2023 ACR guidelines emphasize that hepatocellular predominance requires evaluation for viral hepatitis, fatty liver disease, and autoimmune conditions, while cholestatic predominance requires imaging to exclude biliary obstruction 1.

AST:ALT Ratio Provides Additional Context

• AST:ALT >2 suggests alcohol-induced liver disease 1
• AST:ALT <1 suggests metabolic/NAFLD-related fatty liver 1